Can B Corp. engages in the business of promoting health and wellness through developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass, and the licensing of durable medical devices. The company is headquartered in Hicksville, New York and currently employs 12 full-time employees. The company went IPO on 2011-03-11. The firm is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. The company develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The firm is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.
Follow-Up Questions
Can B Corp 的 CEO 是谁?
Mr. Marco Alfonsi 是 Can B Corp 的 Chairman of the Board,自 2018 加入公司。
CANB 股票的价格表现如何?
CANB 的当前价格为 $0.02,在上个交易日 decreased 了 0%。
Can B Corp 的主要业务主题或行业是什么?
Can B Corp 属于 Pharmaceuticals 行业,该板块是 Health Care
Can B Corp 的市值是多少?
Can B Corp 的当前市值是 $1.5M
Can B Corp 是买入、卖出还是持有?
据华尔街分析师称,共有 3 位分析师对 Can B Corp 进行了分析师评级,包括 2 位强烈买入,4 位买入,1 位持有,0 位卖出,以及 2 位强烈卖出